Mostrar el registro sencillo del ítem

dc.contributor.authorSobrino Reig, Eduardo
dc.contributor.authorMeizoso, Telma
dc.contributor.authorGarcía, Jesús
dc.contributor.authorVarillas Delgado, David 
dc.contributor.authorMartín Martínez, Yasmina 
dc.date.accessioned2022-02-16T13:18:28Z
dc.date.available2022-02-16T13:18:28Z
dc.date.issued2021
dc.identifier.issn1746-1596spa
dc.identifier.urihttp://hdl.handle.net/10641/2829
dc.description.abstractIntroduction Microsatellite instability occurs due to a series of mutations in the DNA pairing error repair (Mismatch repair; MMR) genes, which can affect germ cells as occurs in Lynch syndrome, whose patients are at high risk of developing multiple cancers. The loss of MMR protein is commonly determined by immunohistochemical studies. Although the relation between microsatellite instability and urothelial carcinomas has been widely studied, its evaluation is not currently performed in the analysis of urothelial carcinomas. Methods In this study, the microsatellite status of 139 urothelial carcinomas was analyzed and their clinicopathological characteristics were evaluated. We identified that 10.3% (13 patients) of urothelial carcinomas had loss of MMR protein expression (9 MLH1; 5 MSH2; 2 PMS2; 2 PSH6; n = 139). Results Results suggest that these tumors occur more frequently in males, are more frequently located in the bladder or ureters, and present a high tumor grade with a papillary histological pattern that does not infiltrate the lamina propria or, in the case of infiltrating tumors, that grows into perivesical tissues. Conclusions We identified patients with the aforementioned tumor characteristics as patients with a high probability of presenting loss of MMR protein expression, and consider that only these patients should undergo further immunohistochemical and molecular techniques for proper diagnosis. Therefore, we propose that the clinicopathological characteristics found in the present study could become possible markers to determine which cases should undergo additional tests.spa
dc.language.isoengspa
dc.publisherDiagnostic Pathologyspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectCancerspa
dc.subjectMismatch repairspa
dc.subjectImmunohistochemistryspa
dc.subjectScreening protocolspa
dc.subjectTissue microarrayspa
dc.titleMorphological predictors for microsatellite instability in urothelial carcinoma.spa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent1010 KBspa
dc.identifier.doi10.1186/s13000-021-01168-2spa
dc.relation.publisherversionhttps://diagnosticpathology.biomedcentral.com/articles/10.1186/s13000-021-01168-2spa


Ficheros en el ítem

FicherosTamañoFormatoVer
s13000-021-01168-2.pdf1009.KbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España